Small‐diameter human vessel wall engineered from bone marrow‐derived mesenchymal stem cells (hMSCs)

Using biodegradable scaffold and a biomimetic perfusion system, our lab has successfully engineered small‐diameter vessel grafts using endothelial cells (ECs) and smooth muscle cells (SMCs) obtained from vessels in various species. However, translating this technique into humans has presented tremendous obstacles due to species and age differences. SMCs from elderly persons have limited proliferative capacity and a reduction in collagen production, which impair the mechanical strength of engineered vessels. As an alternative cell source, adult human bone marrow‐derived mesenchymal stem cells (hMSCs) were studied for their ability to differentiate into SMCs in culture plates as well as in a bioreactor system. In the former setting, immunofluorescence staining showed that MSCs, after induction for 14 days, expressed smooth muscle α‐actin (SMA) and calponin, early and mid‐SMC phenotypic markers, respectively. In the latter setting, vessel walls were constructed with MSC‐derived SMCs. Various factors (i.e., matrix proteins, soluble factors, and cyclic strain) in the engineering system were further investigated for their effects on hMSC cell proliferation and differentiation into SMCs. Based on a screening of multiple factors, the engineering system was optimized by dividing the vessel culture into proliferation and differentiation phases. The vessel walls engineered under the optimized conditions were examined histologically and molecularly, and found to be substantially similar to native vessels. In conclusion, bone marrow‐derived hMSCs can serve as a new cell source of SMCs in vessel engineering. Optimization of the culture conditions to drive SMC differentiation and matrix production significantly improved the quality of the hMSC‐derived engineered vessel wall.— Gong Z., Niklason L. E. Small‐diameter human vessel wall engineered from bone marrow‐derived mesenchymal stem cells (hMSCs). FASEB J. 22, 1635–1648 (2008)

[1]  James A Russell,et al.  Functional tissue-engineered blood vessels from bone marrow progenitor cells. , 2007, Cardiovascular research.

[2]  G. Owens,et al.  Platelet-derived growth factor-BB represses smooth muscle cell marker genes via changes in binding of MKL factors and histone deacetylases to their promoters. , 2007, American journal of physiology. Cell physiology.

[3]  Robert T Tranquillo,et al.  Cytokine-induced differentiation of multipotent adult progenitor cells into functional smooth muscle cells. , 2006, The Journal of clinical investigation.

[4]  Jennifer S. Park,et al.  Regulation of vascular smooth muscle cells and mesenchymal stem cells by mechanical strain. , 2006, Molecular & cellular biomechanics : MCB.

[5]  R. Torensma.  Blood vessels engineered from human cells , 2005, The Lancet.

[6]  Seung‐Woo Cho,et al.  Small-Diameter Blood Vessels Engineered With Bone Marrow–Derived Cells , 2005, Annals of surgery.

[7]  L. Devy,et al.  Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors. , 2005, The Journal of clinical investigation.

[8]  Jennifer S. Park,et al.  Differential effects of equiaxial and uniaxial strain on mesenchymal stem cells , 2004, Biotechnology and bioengineering.

[9]  E. Raines.  PDGF and cardiovascular disease. , 2004, Cytokine & growth factor reviews.

[10]  Joyce Bischoff,et al.  Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. , 2004, American journal of physiology. Heart and circulatory physiology.

[11]  C. Betsholtz.  Insight into the physiological functions of PDGF through genetic studies in mice. , 2004, Cytokine & growth factor reviews.

[12]  G. Owens,et al.  Platelet-derived growth factor-BB and Ets-1 transcription factor negatively regulate transcription of multiple smooth muscle cell differentiation marker genes. , 2004, American journal of physiology. Heart and circulatory physiology.

[13]  A. Shuttleworth,et al.  Direct cell contact influences bone marrow mesenchymal stem cell fate. , 2004, The international journal of biochemistry & cell biology.

[14]  L. Niklason,et al.  Clonal Population of Adult Stem Cells: Life Span and Differentiation Potential , 2004, Cell transplantation.

[15]  F. Wezeman,et al.  Inhibitory effect of alcohol on osteogenic differentiation in human bone marrow-derived mesenchymal stem cells. , 2004, Alcoholism, clinical and experimental research.

[16]  Y. Ikada,et al.  First Evidence That Bone Marrow Cells Contribute to the Construction of Tissue-Engineered Vascular Autografts In Vivo , 2003, Circulation.

[17]  Laura E Niklason,et al.  Human arteries engineered in vitro , 2003, EMBO reports.

[18]  Michael Sacks,et al.  Thoracic Surgery Directors Association Award. Bone marrow as a cell source for tissue engineering heart valves. , 2003, The Annals of thoracic surgery.

[19]  Min Zhu,et al.  Human adipose tissue is a source of multipotent stem cells. , 2002, Molecular biology of the cell.

[20]  Simon P. Hoerstrup,et al.  Tissue Engineering of Functional Trileaflet Heart Valves From Human Marrow Stromal Cells , 2002, Circulation.

[21]  R. Tuan,et al.  Multilineage mesenchymal differentiation potential of human trabecular bone‐derived cells , 2002, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[22]  M. Spector,et al.  Regulation of smooth muscle actin expression and contraction in adult human mesenchymal stem cells. , 2002, Experimental cell research.

[23]  C. Verfaillie,et al.  Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. , 2002, Experimental hematology.

[24]  Thomas N Robinson,et al.  Cardiovascular Health in Childhood: A Statement for Health Professionals From the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association , 2002, Circulation.

[25]  Simon P Hoerstrup,et al.  A new source for cardiovascular tissue engineering: human bone marrow stromal cells. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[26]  C. Verfaillie,et al.  Human Bone Marrow Stem Cells Exhibit Neural Phenotypes and Ameliorate Neurological Deficits after Grafting into the Ischemic Brain of Rats , 2002, Experimental Neurology.

[27]  Robert M. Nerem,et al.  The Role of Matrix Metalloproteinase-2 in the Remodeling of Cell-Seeded Vascular Constructs Subjected to Cyclic Strain , 2001, Annals of Biomedical Engineering.

[28]  Anthony Atala,et al.  Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo , 2001, Nature Medicine.

[29]  B. Berk.  Vascular smooth muscle growth: autocrine growth mechanisms. , 2001, Physiological reviews.

[30]  R Langer,et al.  Morphologic and mechanical characteristics of engineered bovine arteries. , 2001, Journal of vascular surgery.

[31]  T. Lee,et al.  Differential effects of extracellular matrix proteins on human airway smooth muscle cell proliferation and phenotype. , 2000, American journal of respiratory cell and molecular biology.

[32]  Christopher J. O’Callaghan,et al.  Mechanical Strain–Induced Extracellular Matrix Production by Human Vascular Smooth Muscle Cells: Role of TGF-&bgr;1 , 2000, Hypertension.

[33]  J D Hellums,et al.  Physiological cyclic stretch causes cell cycle arrest in cultured vascular smooth muscle cells. , 2000, American journal of physiology. Heart and circulatory physiology.

[34]  B. Sumpio,et al.  Clinical and biological relevance of vein cuff anastomosis. , 1999, Acta chirurgica Belgica.

[35]  Laura E. Niklason,et al.  Replacement Arteries Made to Order , 1999, Science.

[36]  David J. Mooney,et al.  Cyclic mechanical strain regulates the development of engineered smooth muscle tissue , 1999, Nature Biotechnology.

[37]  R Langer,et al.  Functional arteries grown in vitro. , 1999, Science.

[38]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[39]  J. Aubin.  Osteoprogenitor cell frequency in rat bone marrow stromal populations: Role for heterotypic cell–cell interactions in osteoblast differentiation , 1999, Journal of cellular biochemistry.

[40]  C. Heldin,et al.  Mechanism of action and in vivo role of platelet-derived growth factor. , 1999, Physiological reviews.

[41]  K. Hirschi,et al.  PDGF, TGF-β, and Heterotypic Cell–Cell Interactions Mediate Endothelial Cell–induced Recruitment of 10T1/2 Cells and Their Differentiation to a Smooth Muscle Fate , 1998, The Journal of cell biology.

[42]  A. Ooshima,et al.  Stretch-induced proliferation of cultured vascular smooth muscle cells and a possible involvement of local renin-angiotensin system and platelet-derived growth factor (PDGF). , 1997, Hypertension research : official journal of the Japanese Society of Hypertension.

[43]  G. Owens,et al.  A Transforming Growth Factor β (TGFβ) Control Element Drives TGFβ-induced Stimulation of Smooth Muscle α-Actin Gene Expression in Concert with Two CArG Elements* , 1997, The Journal of Biological Chemistry.

[44]  B. Sumpio,et al.  Strain activation of bovine aortic smooth muscle cell proliferation and alignment: Study of strain dependency and the role of protein kinase A and C signaling pathways , 1997, Journal of cellular physiology.

[45]  G. V. van Eys,et al.  Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells , 1996, The Journal of cell biology.

[46]  G. Owens,et al.  Regulation of differentiation of vascular smooth muscle cells. , 1995, Physiological reviews.

[47]  Konstantin G. Birukov,et al.  Stretch affects phenotype and proliferation of vascular smooth muscle cells , 1995, Molecular and Cellular Biochemistry.

[48]  P. Hervé,et al.  Nontransformed colony-derived stromal cell lines from normal human marrows. II. Phenotypic characterization and differentiation pathway. , 1995, Experimental hematology.

[49]  K. Marotti,et al.  Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein , 1993, Nature.

[50]  V. Koteliansky,et al.  Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway. , 1993, Blood.

[51]  E. Lakatta,et al.  Experimental models that mimic the differentiation and dedifferentiation of vascular cells. , 1992, Circulation.

[52]  T. Allen,et al.  Transforming growth factor beta 1 promotes the differentiation of endothelial cells into smooth muscle-like cells in vitro. , 1992, Journal of cell science.

[53]  Arnold I. Caplan,et al.  Mesenchymal Stem Cells , 1991, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[54]  S. Björkerud.  Effects of transforming growth factor-beta 1 on human arterial smooth muscle cells in vitro. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[55]  G. Gabbiani,et al.  Expression of α‐sooth‐muscle actin in stromal cells of the uterine cervix during epithlial neoplastic changes , 1991 .

[56]  R. Kramer,et al.  Integrin receptors on aortic smooth muscle cells mediate adhesion to fibronectin, laminin, and collagen. , 1990, Circulation research.

[57]  G. Gabbiani,et al.  Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[58]  J. Lessard,et al.  Cellular distribution of smooth muscle actins during mammalian embryogenesis: expression of the alpha-vascular but not the gamma- enteric isoform in differentiating striated myocytes , 1989, The Journal of cell biology.

[59]  J. Thyberg,et al.  A substrate of the cell-attachment sequence of fibronectin (Arg-Gly-Asp-Ser) is sufficient to promote transition of arterial smooth muscle cells from a contractile to a synthetic phenotype. , 1989, Developmental biology.

[60]  R. Schwartz,et al.  Sequential activation of alpha-actin genes during avian cardiogenesis: vascular smooth muscle alpha-actin gene transcripts mark the onset of cardiomyocyte differentiation , 1988, The Journal of cell biology.

[61]  H. Weintraub,et al.  Expression of a single transfected cDNA converts fibroblasts to myoblasts , 1987, Cell.

[62]  R. Chard,et al.  Aorta-coronary bypass grafting with polytetrafluoroethylene conduits. Early and late outcome in eight patients. , 1987, The Journal of thoracic and cardiovascular surgery.

[63]  R. Majack.  Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures , 1987, The Journal of cell biology.

[64]  E Bell,et al.  A blood vessel model constructed from collagen and cultured vascular cells. , 1986, Science.

[65]  J. Chamley-Campbell,et al.  What controls smooth muscle phenotype? , 1981, Atherosclerosis.

[66]  R. Sapsford,et al.  Early and late patency of expanded polytetrafluoroethylene vascular grafts in aorta-coronary bypass. , 1981, The Journal of thoracic and cardiovascular surgery.

[67]  N. Kulagina,et al.  Fibroblast precursors in normal and irradiated mouse hematopoietic organs. , 1976, Experimental hematology.

[68]  J. F. Woessner,et al.  The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. , 1961, Archives of biochemistry and biophysics.

[69]  Catherine M. Verfaillie,et al.  Pluripotency of mesenchymal stem cells derived from adult marrow , 2007, Nature.

[70]  L. Niklason,et al.  Small-Diameter Vascular Grafts , 2002 .

[71]  D E Ingber,et al.  Cellular tensegrity: exploring how mechanical changes in the cytoskeleton regulate cell growth, migration, and tissue pattern during morphogenesis. , 1994, International review of cytology.

[72]  A. Caplan,et al.  Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. , 1992, Bone.

[73]  G. Gabbiani,et al.  Expression of alpha-smooth-muscle actin in stromal cells of the uterine cervix during epithelial neoplastic changes. , 1991, International journal of cancer.

[74]  D. Carey,et al.  Control of growth and differentiation of vascular cells by extracellular matrix proteins. , 1991, Annual review of physiology.

[75]  V. Bernhard,et al.  Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. , 1986, Journal of vascular surgery.

[76]  R. Ross,et al.  The smooth muscle cell in culture. , 1979, Physiological reviews.